article thumbnail

STAT+: FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents

STAT

Amid ongoing concern over the quality of medicines made in India, a major supplier of generic medicines was seen removing three truckloads of “scrap materials” from a facility that was being inspected last month by the Food and Drug Administration.

article thumbnail

India considers policy change after cough syrup deaths, a document from PM’s office

Express Pharma

“Tweak in policy is mooted,” the document from the prime minister’s office said, adding that “important things” had been “overlooked” It did not elaborate. Increased testing of cough syrups as well as of raw materials for drugs in general is one of the steps being considered, said the source.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Charting India Pharma Inc’s growth path

Express Pharma

India Pharma Inc, hailed for its prowess in the production of high-quality generic medicines, now needs to shift from a conventional, volume-based business strategy to a value-based approach to keep it up its growth momentum. In this context, finding the right opportunities and understanding the challenges has become crucial.

article thumbnail

Generic drug development: The way forward

Express Pharma

The pundits are unanimous in their response – changes in the US generic drug market. The US is the biggest market for generic medicines (~90 per cent of prescriptions are fulfilled by generic drugs). What is the reason behind this lull as far as the Indian life science companies are concerned?

article thumbnail

Halting Europe’s essential medicines manufacturing exodus

European Pharmaceutical Review

This is long overdue as the current tender process has been one of the root causes for the decline in Europe’s essential medicines manufacturing due to the sole focus on price, to the exclusion of other factors like quality and sustainability of supply.

article thumbnail

Maximise Profit by Becoming a Drug Tariff Pro

pharmacy mentor

Drug Tariff Basics The NHS Drug Tariff is a crucial document that sets out pharmacy remuneration and reimbursement rates across England and Wales, acting as the foundation for pharmacy business operations. Without this careful management, you risk dispensing at a loss, especially when dealing with high-volume or costly medications.

article thumbnail

PMPRB launches consultation on revised Draft Guidelines

Pharma in Brief

Medicines that do not fall into one of the three groups of existing patented medicines will be regulated as new patented medicines and assigned to either Category I or Category II. Medicines falling below these thresholds, as well as biosimilars and generics, will be classified as Category II.